The Valley Desk

NCT03594058 · Interventional trial

A Study to Evaluate Once Daily Low Dose and High Dose Solabegron or Placebo Given for 12 Weeks to Treat Women With Symptoms of Overactive Bladder: Sudden Urge to Urinate, Frequent Urination Associated With Wetting Episodes (VEL-2001)

Overall registry status Completed

Phase 2

Conditions Overactive Bladder

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov